scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0735-1097(99)00448-9 |
P698 | PubMed publication ID | 10588212 |
P2093 | author name string | J Willeit | |
S Kiechl | |||
G Egger | |||
C J Wiedermann | |||
S Dunzendorfer | |||
P Schratzberger | |||
F Oberhollenzer | |||
P2860 | cites work | The Measurement of Observer Agreement for Categorical Data | Q26778373 |
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old) | Q34086738 | ||
Inducible interleukin-1 gene expression in human vascular smooth muscle cells | Q34548807 | ||
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures | Q35768215 | ||
Novel vascular molecule involved in monocyte adhesion to aortic endothelium in models of atherogenesis. | Q36377355 | ||
Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction | Q37880581 | ||
Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research | Q37881887 | ||
Chronic infections and coronary heart disease: is there a link? | Q37882245 | ||
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery | Q37886058 | ||
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors | Q37886448 | ||
Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease | Q37892814 | ||
Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 | ||
Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease | Q37894988 | ||
The pathogenesis of atherosclerosis--an update | Q39726917 | ||
Dose-response relationship to inhaled endotoxin in normal subjects | Q40645332 | ||
Periodontal disease and cardiovascular disease | Q41204551 | ||
Atherogenic Diets Enhance Endotoxin-Stimulated Interleukin-1 and Tumor Necrosis Factor Gene Expression in Rabbit Aortae | Q42468058 | ||
Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study | Q45221518 | ||
Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. | Q50919576 | ||
Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. | Q51012002 | ||
Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. | Q51055733 | ||
Lipopolysaccharide induces hyperadhesion of endothelial cells for neutrophils leading to damage. | Q54626960 | ||
Cumulative Effects of High Cholesterol Levels, High Blood Pressure, and Cigarette Smoking on Carotid Stenosis | Q57746052 | ||
Cigarettes are a rich source of bacterial endotoxin | Q70993324 | ||
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy | Q71210092 | ||
Does atherosclerosis have an infectious etiology? | Q71493511 | ||
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial | Q71512983 | ||
Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects | Q73832958 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endotoxemia | Q5832599 |
cardiovascular disease | Q389735 | ||
P304 | page(s) | 1975-1981 | |
P577 | publication date | 1999-12-01 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study | |
P478 | volume | 34 |
Q36621631 | 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. |
Q57792124 | 5,2'-dibromo-2,4',5'-trihydroxydiphenylmethanone attenuates LPS-induced inflammation and ROS production in EA.hy926 cells via HMBOX1 induction |
Q42291031 | A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1. |
Q61883672 | A central role for monocytes in Toll-like receptor-mediated activation of the vasculature |
Q34084463 | A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese |
Q98196693 | A possible beneficial effect of Bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases |
Q42122755 | Abnormal macrophage response to microbial stimulus in a 43-year-old man with a severe form of atherosclerosis: a case report |
Q37240994 | Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway |
Q33940856 | Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis |
Q92860877 | Adaptation and memory in immune responses |
Q34963676 | Adiponectin protein exists in aortic endothelial cells |
Q37574992 | Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle |
Q59798581 | Altered gut microbiota after traumatic splenectomy is associated with endotoxemia |
Q47099574 | Anti-inflammatory evaluation of the methanolic extract of Taraxacum officinale in LPS-stimulated human umbilical vein endothelial cells |
Q57457620 | Are toll-like receptors potential drug targets for atherosclerosis? Evidence from genetic studies to date |
Q37079653 | Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis |
Q36025615 | Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD. |
Q90361660 | Blood Microbiota Modification After Myocardial Infarction Depends Upon Low-Density Lipoprotein Cholesterol Levels |
Q34571191 | Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study |
Q58106596 | C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet |
Q35197222 | Cardiovascular complications in inflammatory bowel disease. |
Q37401827 | Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats |
Q54233821 | Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD. |
Q35641502 | Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients |
Q53039065 | Consumption of a High-fat Meal was associated with an Increase in Monocyte Adhesion Molecules, Scavenger Receptors, and Propensity to Form Foam Cells. |
Q30318502 | Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis |
Q37869369 | Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques |
Q35087841 | Diabetic complications and dysregulated innate immunity |
Q36456727 | Differential TNF production by monocyte subsets under physical stress: blunted mobilization of proinflammatory monocytes in prehypertensive individuals |
Q33633640 | Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin |
Q40638929 | Effects of Porphyromnonas gingivalis lipopolysaccharide on the expression of RANTES and fractalkine in human urnbilical vein endothelial cells |
Q34061842 | Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation |
Q34785885 | Endotoxemia and the host systemic response during experimental gingivitis |
Q33901115 | Endotoxemia is associated with acute coronary syndrome in patients with end stage kidney disease |
Q36666840 | Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients |
Q42540372 | Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients |
Q51538107 | Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease. |
Q73250265 | Endotoxin: another phantom menace? |
Q53882623 | Endovascular stent-graft placement versus conventional open surgery in infrarenal aortic aneurysm: a prospective study on acute phase response and clinical outcome. |
Q35622521 | Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients |
Q33821397 | Fecal microbiota transplantation in metabolic syndrome: History, present and future |
Q26748713 | Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease |
Q26747585 | Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats |
Q23919376 | Gender differences in the effect of occupational endotoxin exposure on impaired lung function and death: the Shanghai Textile Worker Study |
Q57623228 | Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy |
Q52680146 | Gut Microbiome in Chronic Kidney Disease. |
Q38836354 | Gut microbiome in chronic kidney disease: challenges and opportunities |
Q35573510 | Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. |
Q88687570 | Gut-derived lipopolysaccharides increase post-prandial oxidative stress via Nox2 activation in patients with impaired fasting glucose tolerance: effect of extra-virgin olive oil |
Q59822020 | High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus r |
Q39396961 | IL-35, as a newly proposed homeostasis-associated molecular pattern, plays three major functions including anti-inflammatory initiator, effector, and blocker in cardiovascular diseases. |
Q34908689 | IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance |
Q37871384 | Immune activation as effect modifier of atherogenesis in chronic infection |
Q39808961 | Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus |
Q91845019 | Immunity, microbiota and kidney disease |
Q35819570 | Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk |
Q34381887 | Impact of contaminated dialysate on long-term haemodialysis-related complications: is it really that important? |
Q43703996 | Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin |
Q37969996 | Infectious complications in dialysis--epidemiology and outcomes |
Q45979250 | Inflammation and exercise: Inhibition of monocytic intracellular TNF production by acute exercise via β2-adrenergic activation. |
Q38370895 | Inflammation-induced foam cell formation in chronic inflammatory disease. |
Q38020262 | Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia |
Q34841012 | Innate immune programing by endotoxin and its pathological consequences |
Q47363732 | Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation |
Q38757951 | Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options. |
Q35725309 | Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? |
Q50333030 | L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils. |
Q34880667 | Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes |
Q42500474 | Lipopolysaccharide represses the expression of ATP-binding cassette transporter G1 and scavenger receptor class B, type I in murine macrophages |
Q33655219 | Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study. |
Q84005774 | Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology |
Q37597310 | Liver X Receptor: Crosstalk Node for the Signaling of Lipid Metabolism, Carbohydrate Metabolism, and Innate Immunity |
Q33997331 | Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia |
Q36599048 | Low-grade inflammatory polarization of monocytes impairs wound healing |
Q57117141 | Metabolic Surgery for the Treatment of Diabetes Mellitus Positioning of Leading Medical Associations in Mexico |
Q33713895 | Microbial translocation and cardiometabolic risk factors in HIV infection |
Q36558287 | Microbial translocation in the pathogenesis of HIV infection and AIDS. |
Q37299999 | Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli |
Q36534100 | Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin |
Q36084187 | Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide |
Q34966302 | Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation |
Q35261976 | Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice |
Q58580826 | New insights on atherosclerosis: A cross-talk between endocannabinoid systems with gut microbiota |
Q44307940 | Nicotine inhibits cardiac apoptosis induced by lipopolysaccharide in rats |
Q61798990 | Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis |
Q35213837 | Obesity, inflammation, and the gut microbiota |
Q90659422 | Phenylbutyrate facilitates homeostasis of non-resolving inflammatory macrophages |
Q40809002 | Pilot experience with opebacan/rBPI 21 in myeloablative hematopoietic cell transplantation |
Q74137367 | Plasma concentrations of bacterial lipopolysaccharide: a marker of infection or inflammation? |
Q37762605 | Polyphenols from red wine are potent modulators of innate and adaptive immune responsiveness. |
Q36012378 | Postprandial Effect of a High-Fat Meal on Endotoxemia in Arab Women with and without Insulin-Resistance-Related Diseases. |
Q42069466 | Potent suppression of arginase 1 expression in murine macrophages by low dose endotoxin |
Q34667902 | Recurrent exposure to subclinical lipopolysaccharide increases mortality and induces cardiac fibrosis in mice |
Q37686347 | Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells |
Q34404759 | Relationship between microbial translocation and endothelial function in HIV infected patients |
Q35198890 | Relationship between postprandial endotoxemia in nonobese postmenopausal women and diabetic nonobese postmenopausal women |
Q26775340 | Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis |
Q87691389 | Risk of cardiovascular disease in inflammatory bowel disease |
Q57111078 | Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies |
Q34555906 | Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice |
Q37215251 | Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis |
Q54737680 | Searching for links between endotoxin exposure and pregnancy loss: CD14 polymorphism in idiopathic recurrent miscarriage. |
Q73322731 | Seek and thou shalt find: bacterial lipopolysaccharide as a possible link between increased CD14 expression, high CRP, and low HDL |
Q89830662 | Serum lipopolysaccharide neutralizing capacity in ischemic stroke |
Q37456616 | Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. |
Q49797519 | South Asian Health: Inflammation, Infection, Exposure, and the Human Microbiome. |
Q34093621 | Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells. |
Q38510131 | Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability |
Q36600936 | Subclinical-Dose Endotoxin Sustains Low-Grade Inflammation and Exacerbates Steatohepatitis in High-Fat Diet-Fed Mice |
Q35654379 | Super-low dose endotoxin pre-conditioning exacerbates sepsis mortality |
Q35135904 | Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells |
Q33941972 | Systemic inflammation in cardiovascular and periodontal disease: comparative study |
Q34430776 | T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis |
Q35030351 | The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals |
Q90733135 | The Dual Role of Surfactant Protein-D in Vascular Inflammation and Development of Cardiovascular Disease |
Q57169434 | The Human Gut Microbiome - A Potential Controller of Wellness and Disease |
Q57492139 | The Role of Gut Microbiota in Atherosclerosis and Hypertension |
Q34297184 | The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice |
Q38555406 | The danger model: questioning an unconvincing theory |
Q43105112 | The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgery-induced amelioration of NASH in obesity. |
Q36551843 | The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes |
Q90098412 | The endotoxin hypothesis of neurodegeneration |
Q35038619 | The gut microbiome as novel cardio-metabolic target: the time has come! |
Q35042986 | The gut microbiome, kidney disease, and targeted interventions |
Q64927277 | The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy. |
Q42564043 | The importance of the presence of aggregatibacter actinomycetemcomitans in sulcus gingivalis of patients with cardiovascular diseases |
Q37408646 | The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis |
Q33639016 | Toll-Interacting Protein in Resolving and Non-Resolving Inflammation |
Q37421811 | Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease |
Q35674383 | Understanding the expression of Toll-like receptors in Asian Indians predisposed to coronary artery disease |
Q36896547 | Vitamin D3 repletion in chronic kidney disease stage 3: effects on blood endotoxin activity, inflammatory cytokines, and intestinal permeability |
Q55025772 | [Effect of glutaredoxin on oxidative stress of umbilical vein endothelial cell exposed to Porphyromonas gingivalis lipo- polysaccharide]. |
Q37352012 | mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells |
Search more.